tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Choi, 37 are a SELL (20.33%), 65 are a HOLD (35.71%), 80 are a BUY (43.96%).
Analyst Paul Choi, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 59.51% that have a potential upside of 34% achieved within 177 days.
Paul Choi’s has documented 378 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Pharmaceuticals sectors.
Most recent stock forecast was given on AMRN, Amarin PLC at 24-Jun-2025.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for VIR (VIR BIOTECHNOLOGY) at 3/1/2021. The price target of $61 was fulfilled within 1 day with a profit of $5.73 (8.59%) receiving and performance score of 85.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$3
$1.79 (147.93%)
$3
1 years 15 days ago
(26-Sep-2024)
0/4 (0%)
$2.42 (417.24%)
Hold
$7
1 years 3 months 21 days ago
(20-Jun-2024)
1/3 (33.33%)
$0.45 (6.87%)
57
Sell
$1
$-0.21 (-17.36%)
$1.5
1 years 8 months 24 days ago
(17-Jan-2024)
6/6 (100%)
$-0.02 (-1.96%)
278
Buy
1 years 9 months 23 days ago
(18-Dec-2023)
1/1 (100%)
$32.69 (83.16%)
358
Buy
$9
$7.79 (643.80%)
2 years 5 months ago
(11-May-2023)
2/4 (50%)
$4.84 (116.35%)
178
Which stock is Paul Choi is most bullish on?
Which stock is Paul Choi is most reserved on?
What Year was the first public recommendation made by Paul Choi?
